N/A N=101 Indirect Cost of Illness Study of Moderate and Severe Asthma in Quebec
Asthma
Primary: Indirect Cost of Asthma Per Participant Per 3 Months at Baseline (BL) and 12-month Follow-up (FUP) — 253.3; 70.4; 16.9; 17.1 US Dollars
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=292 Asthma in Central Texas Project
Asthma
Primary: Absenteeism, End of Study — 3.83; 4.41; 3.68 percentage of days enrolled
N/A N=384 Telemedicine Enhanced Asthma Management Through the Emergency Department
Asthma
Primary: Number of Symptom-Free Days in the Prior 2 Weeks — 9.5; 10.1 days
Phase 4 N=13 ED-Initiated School-based Asthma Medication Supervision
Asthma · Asthma in Children
Primary: 90-day Emergency Department (ED) Recidivism — 1; 2 Participants
N/A N=56 Asthma in Families Facing Out-of-pocket Requirements Due to COVID-19
Asthma
Primary: Insurance Coverage — 11; 17; 1; 8 Participants
N/A N=849 The Electronic Asthma Action Plan System for Implementation in Primary Care
Asthma
Primary: Number of Participants to Whom an AAP (Asthma Action Plan) Was Delivered by the Clinician — 0; 79 Participants
N/A N=66 Academic Achievement in Children With Asthma
Asthma
Primary: GPA — 2.75; 2.61; 3.25; 2.50 GPA(unweighted)
N/A N=26 The Effect of Montelukast on Asthma Control in Overweight/Obese Atopic Asthmatics
Asthma · Obesity · Inflammation
Primary: Asthma Control Test (ACT) Scores — 25.00; 20.5; 24.00; 15.75 units on a scale
Phase 4 N=52 Positive Expiratory Pressure for the Treatment of Acute Asthma in Children
Asthma
Primary: Change in Pulmonary Asthma Score (PAS) — 0.9; 0.4 mean PAS score
N/A N=12,238 Asthma in Families Facing Out-of-pocket Requirements With Deductibles
Asthma
Primary: Change in Percentage of Days Covered for Inhaled Corticosteroids — 51.5; 44.7; 37.0; 29.1 percentage of days — p=0.05
Phase 3 N=211 Characterization of the Role of Histamine in Children With Asthma
Asthma · Allergic Asthma · Non-allergic Asthma
Primary: Characterize Contribution of Histamine in Children With Asthma — 11253.24; 6464.20; 3539.67 flux units on a continuous scale
Phase 4 N=1,220 Patient Empowered Strategy to Reduce Asthma Morbidity in Highly Impacted Populations; PeRson EmPowered Asthma RElief
Asthma
Primary: Rate of Asthma Exacerbations Per Year — 0.69; 0.82 Adjusted annualized exacerbations — p=0.048
Phase 2 N=371 Peer Led Asthma Self Management for Adolescents: PLASMA
Asthma
Primary: The Pediatric Asthma Quality of Life Questionnaire (PAQOL) — 5.58; 5.93; 6.49 score on a scale — p=.043
N/A N=398 Reducing Asthma Morbidity In High Risk Minority Preschool Children
Asthma
Primary: Asthma Control as Determined by Test for Respiratory and Asthma Control in Kids Assessment Tool — 70; 75; 85; 80 score on a scale
N/A N=530 School-based Asthma Therapy: Stage 2 Effectiveness Study
Asthma
Primary: Number of Symptom Free Days — 10.7; 11.6 Days